Abstract:Objective To assess the value of noninvasive MR imaging biomarkers in evaluating the early efficacy of anti?angiogenesis drugs. Methods Subcutaneous colon cancer xenograft models in thirty nude mice were established. The mice were randomly divided into three groups (n=10 for each): avastin injection group (dose 10 mg/kg), fluorouracil group (dose 150 mg/kg), physiological saline group (dose 20 mg/kg). Dynamic contrast?enhanced (DCE?MRI) and multiple b value diffusion weighted imaging (muti?b?value DWI) were acquired before or 1 h, 24 h and 48 h after the treatment. The parameters of contrast transfer coefficient (Ktrans), reflux constant (Kep), plasma volume fraction (Vp), extravascular extracellular volume fraction (Ve) and various apparent diffusion coefficients (ADCs) (ADC10b, ADChigh and ADCperf) were measured. Forty eight hours after the treatment, the mice were sacrificed following MRI. Aimmunohistochemical examination determined microvessel density (MVD) and proliferating cell nuclear antigen (PCNA) score. A repeated measures analysis of variance was used to compare the difference between the quantitative parameters among the three groups. A multivariate variance analysis was performed to compare the difference between the parameters at the same time point among the three groups. The correlation between MRI quantitative parameters with MVD and PCNA score were analyzed by Pearson and Spearman correlation analysis respectively. Factor analysis method summarized MRI quantitative parameters. Results One hour after the treatment, the parameters of Ktrans, Kep, ADC10b, ADChigh and ADCperf value immediately changed, they were(0.009 ± 0.005)/s,(0.042 ± 0.031)/s,(0.043 ± 0.002)× 10?3 mm2/s,(0.031 ± 0.005)× 10?3 mm2/s,(0.089 ± 0.006)× 10?3 mm2/s, Ktrans, Kep, ADC10b and ADChigh values all had significant differences in the three groups (F=42.058, 25.979, 9.870 and 8.511, respectively, all P<0.05). There were also statistical difference in the change trend of the above parameters among the three groups (F=22.108, 7.280, 65.698 and 19.900, respectively, all P<0.05). The change trend of ADCperf showed significant difference among the three groups (F=38.780, P<0.01). Ktrans, Kep and ADCperf positively correlated with the MVD count and PCNA score (r values were 0.421 to 0.811, both P<0.01), while ADC10b showed a negative correlation (r=-0.656 and-0.560, both P<0.01), ADChigh had negative correlation with the PCNA score (r=-0.568, P<0.05). Ktrans, Vp, Kep and ADCperf were classified as tumor microcirculation factor, whereas ADC10b and ADChigh were normalized for cell metabolism factor through the factor analysis. Conclusions Combination of DCE?MRI and muti?b?value DWI can reflect the early changes of drug therapy from the aspects of tumor microcirculation and cell metabolism. Ktrans, Kep, ADCperf, ADC10b and ADChigh can be taken as noninvasive imaging biomarkers to quantify the early efficacy of anti?angiogenesis drugs.

Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer

Dynamic Contrast-Enhanced Computed Tomography Functional Imaging for the Evaluation of Tumor Angiogenesis in Patients with Lung Carcinoma

18 F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer.

Dynamic Contrast-enhanced Area-detector CT vs Dynamic Contrast-enhanced Perfusion MRI vs FDG-PET/CT: Comparison of Utility for Quantitative Therapeutic Outcome Prediction for NSCLC Patients Undergoing Chemoradiotherapy

Dynamic Contrast-Enhanced MRI Perfusion Parameters Are Imaging Biomarkers for Angiogenesis in Lung Cancer

Value of Targeted MR Molecular Imaging in Evaluating the Early Efficacy of Anti-Angiogenesis Drugs

The Clinical Pathologic Characteristics Of Angiogenesis Obtained By 18f-Rgd Pet In Patients With Non-Small Cell Lung Cancer

18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment

Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy Via Noninvasive Pet Molecular Imaging Strategies of Multifactorial Bioparameters

Tumor Vascularity And Glucose Metabolism Correlated In Adenocarcinoma, But Not In Squamous Cell Carcinoma Of The Lung

Measurement of Tumor Volume by PET to Evaluate Prognosis in Patients with Advanced Non-Small Cell Lung Cancer Treated by Non-Surgical Therapy

Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis.

Evaluation of clinical outcomes of antiangiogenic-targeted therapy in patients with pulmonary metastatic renal cell carcinoma using non-contrast-enhanced computed tomography.

Relationship Between Tc-99m-3prgd2spect/Ct Imaging And Tumor Angiogenesis In Non-Small Cell Lung Cancer

Correlative Investigation of Dynamic Contrast CT and Positron Emission Tomography with 18-Fluorodeoxy Glucose Standardized Uptake Value in Non-Small Cell Lung Cancer

An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer

Non-small Cell Lung Cancer Evaluated by First Pass Dynamic Contrast-Enhanced 16-Slice Spiral CT:correlation of Tumor Vascularity with Pathological Characteristics

Circulating endothelial cells and tumor blood volume as predictors in lung cancer.

Amide Proton Transfer-Weighted Imaging and Multiple Models Intravoxel Incoherent Motion-Based 18F-FDG PET/MRI for Predicting Progression-Free Survival in Non-Small Cell Lung Cancer

Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer

Usefulness of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Treatment Response to Vinorelbine-Cisplatin with or Without Recombinant Human Endostatin in Bone Metastasis of Non-Small Cell Lung Cancer